The IPKat

DECEMBER 22, 2022

Here is the scoop: Background The Respondent, Novartis, owns a patent EP 2 959 894 for a specific use of fingolimod. They sought an Arrow declaration that the importation, disposal, use and keeping by them of generic fingolimod in the UK for that specific use would have been obvious at the priority date of the patent in question ([5]).

Marketing 82

Marketing Marketing Patent Infringement Patent 82

Patently-O

FEBRUARY 22, 2023

Stroud is General Counsel at Unified Patents – an organization often adverse to litigation-funded entities. [1] Patent assertion finance today is a multibillion-dollar business. [2] 2] Virtually nonexistent in the patent space in the U.S. Patent assertion finance today is a multibillion-dollar business. [2]

Litigation 125

Litigation Reporting Settlement Government 125

SpicyIP

MARCH 25, 2024

Here is our recap of last week’s top IP developments including summaries of posts on the new Patent (Amendment) Rules, and some thoughts on safeguards which can be used by intermediaries to prevent trademark infringement. Some Concerns about the Amendment Process to Key Patent Levers: A “Captured” Patent Office?

Trademark 52

Trademark Patent Copyright Confidentiality 52

The IPKat

JUNE 22, 2023

This observation also applies to Standard Essential Patent (SEP) licensors who may have various levels of bargaining power which may in addition change over time ([247] – [249]). 2019) that the release term was in substance compensatory relief for TCL’s patent infringements when deciding worldwide FRAND terms.

Patent Infringement 87

Patent Infringement Licensing Patent Litigation 87

SpicyIP

MARCH 11, 2024

Highlights of the Week Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case Image from [link] here Recently, the DHC issued directives regarding expert evidence in the Perjeta patent litigation. Read on to know more! SpicyIP Tidbit: The Competition Act v.

Trademark 59

Trademark Registration Copyright Patent 59

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. . No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. Commercial Launch Date. adalimumab-aqvh.

Litigation 52

Litigation Settlement Patent Marketing 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 5, 2022

As the battery and electric vehicle (EV) industries continue to grow, in tandem the IP world is experiencing an increase in battery patenting activity. Research and development in the battery industry have led to a notable increase in patent filings at the U.S. Figure 1: Battery Patent Filings: CPC Class H01M 1. Valued at $108.4

Intellectual Property 52

Intellectual Property Technology Journalism IP 52

The IPKat

SEPTEMBER 12, 2021

The second of these decisions, Abbott v Dexcom [2021] EWHC 2246 , concerned Abbott's latest application to expedite a patent trial revoking four of Dexcom's patents. The injunction gap arises in Germany because infringement is decided before and separately to validity. But no such luck for Abbott, " regret[tably] ".

Litigation 98

Litigation Patent Marketing Marketing 98

LexBlog IP

APRIL 3, 2023

This decision indicates that an SEP owner sometimes might need to provide information to a prospective licensee (under a confidentiality agreement), although that may not be necessary for an experienced licensee who can consult existing patent licenses they have entered with others.

Licensing 52

Licensing Technology Intellectual Property Patent 52